Literature DB >> 36227152

Polarisation of human macrophages towards an M1 subtype triggered by an atypical Brazilian strain of Toxoplasma gondii results in a reduction in parasite burden.

Paula Suellen Guimaraes Gois1, Priscila Silva Franco1, Samuel Cota Teixeira1, Pamela Mendonca Guirelli1, Thadia Evelyn de Araujo1, Deivid William da Fonseca Batistao1, Fernanda Chaves de Oliveira1, Gabriela Licia Santos Ferreira2, Angelica de Oliveira Gomes3, Silvio Favoreto4, Jose Roberto Mineo5, Bellisa de Freitas Barbosa1, Eloisa Amalia Vieira Ferro1.   

Abstract

Toxoplasma gondii Nicolle et Manceaux, 1909, the etiologic agent of toxoplasmosis, was considered a clonal population with three distinct genetic lineages (I, II and III); however, sequence analysis of different strains has revealed distinct atypical genotypes. Macrophages are essential for immunity against toxoplasmosis and differential cell regulation may affect the course of the disease. In this context, our study aims to investigate the infection by TgChBrUD2, a highly virulent atypical Brazilian strain of T. gondii, on the activation and polarisation of human macrophages. Human macrophage-like cells obtained from THP-1 cells were infected with TgChBrUD2, RH or ME49 strains of T. gondii to evaluate the impact of parasite infection on macrophage polarisation. Our results indicate that the TgChBrUD2 and ME49 strains of T. gondii induced a classic activation of human macrophages, which was confirmed by the high rate of spindle-shaped macrophages, low amount of urea and increase in the levels of nitrite, as well as the down-regulation of M2-markers. In contrast, RH strain promoted an alternative activation of macrophages. The polarisation of human macrophages towards an M1 subtype mediated by TgChBrUD2 and ME49 strains resulted in a low parasite burden, with high levels of IL-6 and MIF. Finally, the M2 subtype triggered by the RH strain culminated in a lower intracellular proliferation index. We concluded that the atypical (TgChBrUD2) and clonal (ME49) strains are able to elicit an M1 subtype, which results in parasitism control, partially explained by the high levels of IL-6 and MIF produced during the infection by these genotypes. In contrast, the clonal (RH) strain promoted a macrophage polarisation towards an M2 subtype, marked by a high parasite burden, with a weak modulation of pro-inflammatory cytokines. Thus, atypical strains can present different mechanisms of pathogenicity and transmissibility compared to clonal strains, as well as they can use distinct strategies to evade the host's immune response and ensure their survival.

Entities:  

Keywords:  TgChBrUD2 strain; clonal strains; macrophage polarisation; toxoplasmosis

Mesh:

Substances:

Year:  2022        PMID: 36227152     DOI: 10.14411/fp.2022.020

Source DB:  PubMed          Journal:  Folia Parasitol (Praha)        ISSN: 0015-5683            Impact factor:   1.614


  52 in total

Review 1.  Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology.

Authors:  J P Dubey; E G Lago; S M Gennari; C Su; J L Jones
Journal:  Parasitology       Date:  2012-07-10       Impact factor: 3.234

2.  Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1/2 expression.

Authors:  M B Angeloni; P M Guirelli; P S Franco; B F Barbosa; A O Gomes; A S Castro; N M Silva; O A Martins-Filho; T W P Mineo; D A O Silva; J R Mineo; E A V Ferro
Journal:  Placenta       Date:  2013-09-18       Impact factor: 3.481

3.  Apoptosis and S phase of the cell cycle in BeWo trophoblastic and HeLa cells are differentially modulated by Toxoplasma gondii strain types.

Authors:  M B Angeloni; N M Silva; A S Castro; A O Gomes; D A O Silva; J R Mineo; E A V Ferro
Journal:  Placenta       Date:  2009-07-30       Impact factor: 3.481

4.  Trophoblast cells are able to regulate monocyte activity to control Toxoplasma gondii infection.

Authors:  A S Castro; C M O S Alves; M B Angeloni; A O Gomes; B F Barbosa; P S Franco; D A O Silva; O A Martins-Filho; J R Mineo; T W P Mineo; E A V Ferro
Journal:  Placenta       Date:  2013-01-05       Impact factor: 3.481

Review 5.  Toxoplasmosis in Human and Animals Around the World. Diagnosis and Perspectives in the One Health Approach.

Authors:  Rosangela Aparecida Müller de Barros; Ana Claudia Torrecilhas; Maria Aparecida Moraes Marciano; Monica Leszkowicz Mazuz; Vera Lucia Pereira-Chioccola; Blima Fux
Journal:  Acta Trop       Date:  2022-04-04       Impact factor: 3.112

Review 6.  Toxoplasma gondii, "new" genotypes and virulence.

Authors:  M L Dardé
Journal:  Parasite       Date:  2008-09       Impact factor: 3.000

7.  TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

Authors:  Jerry R Aldridge; Carson E Moseley; David A Boltz; Nicholas J Negovetich; Cory Reynolds; John Franks; Scott A Brown; Peter C Doherty; Robert G Webster; Paul G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

8.  Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii.

Authors:  Ildiko R Dunay; Renato A Damatta; Blima Fux; Rachel Presti; Suellen Greco; Marco Colonna; L David Sibley
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

9.  Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in southeastern Brazil.

Authors:  Ana Carolina Aguiar Vasconcelos Carneiro; Gláucia Manzan Andrade; Júlia Gatti Ladeia Costa; Breno Veloso Pinheiro; Daniel Vitor Vasconcelos-Santos; Adriana Melo Ferreira; Chunlei Su; José Nélio Januário; Ricardo Wagner Almeida Vitor
Journal:  J Clin Microbiol       Date:  2013-01-02       Impact factor: 5.948

Review 10.  The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies.

Authors:  A Alonso Aguirre; Travis Longcore; Michelle Barbieri; Haydee Dabritz; Dolores Hill; Patrice N Klein; Christopher Lepczyk; Emily L Lilly; Rima McLeod; Judith Milcarsky; Caroline E Murphy; Chunlei Su; Elizabeth VanWormer; Robert Yolken; Grant C Sizemore
Journal:  Ecohealth       Date:  2019-04-03       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.